Skip to main content
Erschienen in: General Thoracic and Cardiovascular Surgery 1/2015

01.01.2015 | Current Topics Review Article

Clinical management for complications related to implantable LVAD use

verfasst von: Koichi Toda, Yoshiki Sawa

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

More than 250 continuous flow LVADs have been implanted in Japan during the last 3 years, with 1-year survival rates of 90 %. These excellent results cannot be achieved without VAD teams who know the detail of surgical techniques and perioperative management. Preoperative optimization of RV function is essential and intraoperative managements are focused on adequate balance between right and left ventricle to prevent right ventricular (RV) failure. For postoperative RV failure early institution of temporary RV mechanical support improves outcomes. Immediate CT scanning is crucial if LVAD patients complain of new neurological symptoms. When CT reveals cerebral hemorrhage, INR should be reduced as soon as possible. The driveline (DL) exit site remains a significant source of LVAD-related infections, and orientation and immobilization of the DL is important. Although vacuum assisted closure is useful to facilitate drainage and healing in pump pocket as well as DL infections, urgent heart transplantation, bridging to recovery, or pump exchange may become the only options to eradicate LVAD-related infections. Patients with continuous flow LVAD are more prone to developing de novo aortic insufficiency. Although majority of them can be managed medically, some require surgical intervention. The cause of pump thrombosis is multifactorial, including lowered INR and pump speed, and implantation techniques. It is important to exchange pumps in a timely manner either through a median sternotomy or subcostal incision in highly suspected patients indicated by elevated LDH and left-sided heart failure.
Literatur
1.
Zurück zum Zitat Deng MC, Edwards LB, Hertz MI, et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report—2005. J Heart Lung Transplant. 2005;24:1182–7.PubMedCrossRef Deng MC, Edwards LB, Hertz MI, et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report—2005. J Heart Lung Transplant. 2005;24:1182–7.PubMedCrossRef
2.
Zurück zum Zitat Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.PubMedCrossRef Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.PubMedCrossRef
3.
Zurück zum Zitat Fitzpatrick JR 3rd, Frederick JR, Hiesinger W, et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg. 2009;137:971–7.PubMedCentralPubMedCrossRef Fitzpatrick JR 3rd, Frederick JR, Hiesinger W, et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg. 2009;137:971–7.PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Fukui S, Matsumiya G, Toda K, et al. Recovery from hemorrhagic pulmonary damage by combined use of a left ventricular assist system and right ventricular assist system and extracorporeal membrane oxygenation. J Heart Lung Transplant. 2006;25:248–50.PubMedCrossRef Fukui S, Matsumiya G, Toda K, et al. Recovery from hemorrhagic pulmonary damage by combined use of a left ventricular assist system and right ventricular assist system and extracorporeal membrane oxygenation. J Heart Lung Transplant. 2006;25:248–50.PubMedCrossRef
5.
Zurück zum Zitat Saito S, Sakaguchi T, Miyagawa S, et al. Biventricular support using implantable continuous-flow ventricular assist devices. J Heart Lung Transplant. 2011;30:475–8.PubMedCrossRef Saito S, Sakaguchi T, Miyagawa S, et al. Biventricular support using implantable continuous-flow ventricular assist devices. J Heart Lung Transplant. 2011;30:475–8.PubMedCrossRef
6.
Zurück zum Zitat Cohn WE, Gregoric ID, Frazier OH. Staged reoperation: a novel strategy for high-risk patients. Ann Thorac Surg. 2007;83:1558–9.PubMedCrossRef Cohn WE, Gregoric ID, Frazier OH. Staged reoperation: a novel strategy for high-risk patients. Ann Thorac Surg. 2007;83:1558–9.PubMedCrossRef
7.
Zurück zum Zitat Stulak JM, Romans T, Cowger J, et al. Delayed sternal closure does not increase late infection risk in patients undergoing left ventricular assist device implantation. J Heart Lung Transplant. 2012;31:1115–9.PubMedCrossRef Stulak JM, Romans T, Cowger J, et al. Delayed sternal closure does not increase late infection risk in patients undergoing left ventricular assist device implantation. J Heart Lung Transplant. 2012;31:1115–9.PubMedCrossRef
8.
Zurück zum Zitat Slaughter MS, Naka Y, John R, et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J Heart Lung Transplant. 2010;29:616–24.PubMedCrossRef Slaughter MS, Naka Y, John R, et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J Heart Lung Transplant. 2010;29:616–24.PubMedCrossRef
9.
Zurück zum Zitat Kormos RL, Holman WL. Adverse events and complications of mechanical circulatory support. Mechanical circulatory support. Philadelphia: Elsevier; 2012. p. 165–82. Kormos RL, Holman WL. Adverse events and complications of mechanical circulatory support. Mechanical circulatory support. Philadelphia: Elsevier; 2012. p. 165–82.
10.
Zurück zum Zitat Masotti L, Di Napoli M, Godoy DA, et al. The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy. Int J Stroke. 2011;6:228–40.PubMedCrossRef Masotti L, Di Napoli M, Godoy DA, et al. The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy. Int J Stroke. 2011;6:228–40.PubMedCrossRef
11.
Zurück zum Zitat Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465–70.PubMedCrossRef Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465–70.PubMedCrossRef
12.
Zurück zum Zitat Mehra MR, Stewart GC, Uber PA. The vexing problem of thrombosis in long-term mechanical circulatory support. J Heart Lung Transplant. 2014;33:1–11.PubMedCrossRef Mehra MR, Stewart GC, Uber PA. The vexing problem of thrombosis in long-term mechanical circulatory support. J Heart Lung Transplant. 2014;33:1–11.PubMedCrossRef
13.
Zurück zum Zitat Akhter SA, Ewald GA, Walsh MN, et al. Preliminary results for driveline site infection from the multicenter silicone-skin-interface (SSI) registry. Presented at ASAIO 2013. Akhter SA, Ewald GA, Walsh MN, et al. Preliminary results for driveline site infection from the multicenter silicone-skin-interface (SSI) registry. Presented at ASAIO 2013.
14.
Zurück zum Zitat Fleissner F, Avsar M, Malehsa D, Strueber M, Haverich A, Schmitto JD. Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices. Artif Organs. 2013;37:102–7.PubMedCrossRef Fleissner F, Avsar M, Malehsa D, Strueber M, Haverich A, Schmitto JD. Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices. Artif Organs. 2013;37:102–7.PubMedCrossRef
15.
Zurück zum Zitat Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J. 2005;51:461–70.PubMedCrossRef Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J. 2005;51:461–70.PubMedCrossRef
16.
Zurück zum Zitat Toda K, Yonemoto Y, Fujita T, et al. Risk analysis of bloodstream infection during long-term left ventricular assist device support. Ann Thorac Surg. 2012;94:1387–93.PubMedCrossRef Toda K, Yonemoto Y, Fujita T, et al. Risk analysis of bloodstream infection during long-term left ventricular assist device support. Ann Thorac Surg. 2012;94:1387–93.PubMedCrossRef
17.
Zurück zum Zitat Gordon SM, Schmitt SK, Jacobs M, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg. 2001;72:725–30.PubMedCrossRef Gordon SM, Schmitt SK, Jacobs M, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg. 2001;72:725–30.PubMedCrossRef
18.
Zurück zum Zitat Baradarian S, Stahovich M, Krause S, Adamson R, Dembitsky W. Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy. ASAIO J. 2006;52:354–6.PubMedCrossRef Baradarian S, Stahovich M, Krause S, Adamson R, Dembitsky W. Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy. ASAIO J. 2006;52:354–6.PubMedCrossRef
19.
Zurück zum Zitat Poston RS, Husain S, Sorce D, et al. LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant. 2003;22:914–21.PubMedCrossRef Poston RS, Husain S, Sorce D, et al. LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant. 2003;22:914–21.PubMedCrossRef
20.
Zurück zum Zitat Yoshioka D, Toda K, Sakaguchi T, et al. Initial report of bridge to recovery in a patient with DuraHeart LVAD. J Artif Organs. 2013;16:386–8.PubMedCrossRef Yoshioka D, Toda K, Sakaguchi T, et al. Initial report of bridge to recovery in a patient with DuraHeart LVAD. J Artif Organs. 2013;16:386–8.PubMedCrossRef
21.
Zurück zum Zitat Nurozler F, Argenziano M, Oz MC, Naka Y. Fungal left ventricular assist device endocarditis. Ann Thorac Surg. 2001;71:614–8.PubMedCrossRef Nurozler F, Argenziano M, Oz MC, Naka Y. Fungal left ventricular assist device endocarditis. Ann Thorac Surg. 2001;71:614–8.PubMedCrossRef
22.
Zurück zum Zitat Robertson JO, Durrani AK, Mihaljevic T. Early failure of bioprostheses caused by adhesion of preserved leaflets after chordal-sparing mitral valve replacement. J Thorac Cardiovasc Surg. 2008;135:1180–1.PubMedCrossRef Robertson JO, Durrani AK, Mihaljevic T. Early failure of bioprostheses caused by adhesion of preserved leaflets after chordal-sparing mitral valve replacement. J Thorac Cardiovasc Surg. 2008;135:1180–1.PubMedCrossRef
23.
Zurück zum Zitat Kitada S, Kato TS, Thomas SS, et al. Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation. J Heart Lung Transplant. 2013;32(9):897–904.PubMedCentralPubMedCrossRef Kitada S, Kato TS, Thomas SS, et al. Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation. J Heart Lung Transplant. 2013;32(9):897–904.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Park SJ, Liao KK, Segurola R, Madhu KP, Miller LW. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park’s stitch). J Thorac Cardiovasc Surg. 2004;127:264–6.PubMedCrossRef Park SJ, Liao KK, Segurola R, Madhu KP, Miller LW. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park’s stitch). J Thorac Cardiovasc Surg. 2004;127:264–6.PubMedCrossRef
25.
Zurück zum Zitat Adamson RM, Dembitsky WP, Baradarian S, et al. Aortic valve closure associated with HeartMate left ventricular device support: technical considerations and long-term results. J Heart Lung Transplant. 2011;30:576–82.PubMedCrossRef Adamson RM, Dembitsky WP, Baradarian S, et al. Aortic valve closure associated with HeartMate left ventricular device support: technical considerations and long-term results. J Heart Lung Transplant. 2011;30:576–82.PubMedCrossRef
26.
Zurück zum Zitat Dembitsky W, Naka Y. Intraoperative management issues in mechanical circulatory support. Mechanical circulatory support. Philadelphia: Elsevier; 2012. p. 153–64. Dembitsky W, Naka Y. Intraoperative management issues in mechanical circulatory support. Mechanical circulatory support. Philadelphia: Elsevier; 2012. p. 153–64.
27.
Zurück zum Zitat Atkins BZ, Hashmi ZA, Ganapathi AM, et al. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2013;146:1247–52.PubMedCrossRef Atkins BZ, Hashmi ZA, Ganapathi AM, et al. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2013;146:1247–52.PubMedCrossRef
28.
Zurück zum Zitat D’Ancona G, Pasic M, Buz S, et al. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device. Ann Thorac Surg. 2012;93:e89–91.PubMedCrossRef D’Ancona G, Pasic M, Buz S, et al. TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device. Ann Thorac Surg. 2012;93:e89–91.PubMedCrossRef
29.
Zurück zum Zitat Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370:33–40.PubMedCrossRef Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370:33–40.PubMedCrossRef
30.
Zurück zum Zitat Sakaguchi T, Matsumiya G, Yoshioka D, et al. DuraHeart™ magnetically levitated left ventricular assist device: Osaka University experience. Circ J. 2013;77:1736–41.PubMedCrossRef Sakaguchi T, Matsumiya G, Yoshioka D, et al. DuraHeart™ magnetically levitated left ventricular assist device: Osaka University experience. Circ J. 2013;77:1736–41.PubMedCrossRef
31.
Zurück zum Zitat Saito S, Yamazaki K, Nishinaka T, et al. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS. J Heart Lung Transplant. 2014;33(6):599–608.PubMedCrossRef Saito S, Yamazaki K, Nishinaka T, et al. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS. J Heart Lung Transplant. 2014;33(6):599–608.PubMedCrossRef
32.
Zurück zum Zitat Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014;33:23–34.PubMedCrossRef Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014;33:23–34.PubMedCrossRef
33.
Zurück zum Zitat Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33:12–22.PubMedCrossRef Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33:12–22.PubMedCrossRef
34.
Zurück zum Zitat Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881–7.PubMedCrossRef Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881–7.PubMedCrossRef
35.
Zurück zum Zitat Taghavi S, Ward C, Jayarajan SN, Gaughan J, Wilson LM, Mangi AA. Surgical technique influences HeartMate II left ventricular assist device thrombosis. Ann Thorac Surg. 2013;96:1259–65.PubMedCrossRef Taghavi S, Ward C, Jayarajan SN, Gaughan J, Wilson LM, Mangi AA. Surgical technique influences HeartMate II left ventricular assist device thrombosis. Ann Thorac Surg. 2013;96:1259–65.PubMedCrossRef
36.
Zurück zum Zitat Shah P, Mehta VM, Cowger JA, Aaronson KD, Pagani FD. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support. J Heart Lung Transplant. 2014;33:102–4.PubMedCrossRef Shah P, Mehta VM, Cowger JA, Aaronson KD, Pagani FD. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support. J Heart Lung Transplant. 2014;33:102–4.PubMedCrossRef
37.
Zurück zum Zitat Uriel N, Han J, Morrison KA, et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant. 2014;33:51–9.PubMedCrossRef Uriel N, Han J, Morrison KA, et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant. 2014;33:51–9.PubMedCrossRef
38.
Zurück zum Zitat Ota T, Yerebakan H, Akashi H, et al. Continuous-flow left ventricular assist device exchange: clinical outcomes. J Heart Lung Transplant. 2014;33:65–70.PubMedCrossRef Ota T, Yerebakan H, Akashi H, et al. Continuous-flow left ventricular assist device exchange: clinical outcomes. J Heart Lung Transplant. 2014;33:65–70.PubMedCrossRef
Metadaten
Titel
Clinical management for complications related to implantable LVAD use
verfasst von
Koichi Toda
Yoshiki Sawa
Publikationsdatum
01.01.2015
Verlag
Springer Japan
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 1/2015
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-014-0480-0

Weitere Artikel der Ausgabe 1/2015

General Thoracic and Cardiovascular Surgery 1/2015 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.